MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAFV600E Mutation Detected in Circulating-Free DNA
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAFV600E Mutation Detected in Circulating-Free DNA
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-08-14
DOI
10.3389/fphar.2018.00856
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cutaneous melanoma: From pathogenesis to therapy (Review)
- (2018) Giulia Leonardi et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers
- (2018) Casey L. Ross et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies
- (2018) Lena Gorgannezhad et al. LAB ON A CHIP
- Is nonmetastatic cutaneous melanoma predictable through genomic biomarkers?
- (2018) Mattia Branca et al. MELANOMA RESEARCH
- Survival of patients with advanced metastatic melanoma: the impact of novel therapies–update 2017
- (2017) Selma Ugurel et al. EUROPEAN JOURNAL OF CANCER
- Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma
- (2017) Lan Yang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review
- (2017) Alicia Brunssen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The need for a network to establish and validate predictive biomarkers in cancer immunotherapy
- (2017) Giuseppe V. Masucci et al. Journal of Translational Medicine
- Immune checkpoint inhibitors in sarcomas: in quest of predictive biomarkers
- (2017) Robin Veenstra et al. LABORATORY INVESTIGATION
- NF-κB inhibition is associated with OPN/MMP-9 downregulation in cutaneous melanoma
- (2017) Claudio Guarneri et al. ONCOLOGY REPORTS
- Therapeutic efficacy and safety of combined BRAF and MEK inhibition in patients with malignant melanoma: a meta-analysis
- (2017) Peng Chen et al. OncoTargets and Therapy
- MicroRNAs in melanoma development and resistance to target therapy
- (2017) Luigi Fattore et al. Oncotarget
- Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications
- (2017) Benoit Busser et al. Biomed Research International
- Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways
- (2017) Sha Liu et al. Cancer Medicine
- Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review
- (2016) Francesco Spagnolo et al. CANCER TREATMENT REVIEWS
- Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors
- (2016) Max Schreuer et al. Journal of Translational Medicine
- COSMIC: somatic cancer genetics at high-resolution
- (2016) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation
- (2016) Silvana Sandri et al. PHARMACOLOGICAL RESEARCH
- The genomic landscape of cutaneous melanoma
- (2016) Tongwu Zhang et al. Pigment Cell & Melanoma Research
- miR-579-3p controls melanoma progression and resistance to target therapy
- (2016) Luigi Fattore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer
- (2016) Luca Falzone et al. Oncotarget
- Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials
- (2015) A. Santiago-Walker et al. CLINICAL CANCER RESEARCH
- Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways
- (2015) Yu-Jen Wu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Extracellular galectin-3 induces MMP9 expression by activating p38 MAPK pathway via lysosome-associated membrane protein-1 (LAMP1)
- (2015) Manohar C. Dange et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Liquiritigenin Potentiates the Inhibitory Effects of Cisplatin on Invasion and Metastasis Via Downregulation MMP-2/9 and PI3 K/AKT Signaling Pathway in B16F10 Melanoma Cells and Mice Model
- (2015) Hui Shi et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
- (2015) Elin S. Gray et al. Oncotarget
- Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation
- (2015) Veronique Mathieu et al. Oncotarget
- Quantitative Cell-Free Circulating BRAFV600E Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF Inhibitors
- (2014) M. F. Sanmamed et al. CLINICAL CHEMISTRY
- β-Elemene inhibits the metastasis of B16F10 melanoma cells by downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9
- (2014) Hong Shi et al. MELANOMA RESEARCH
- RNAi-mediated MMP-9 silencing inhibits mouse melanoma cell invasion and migration in vitro and in vivo
- (2013) Zhao-Yong Tang et al. CELL BIOLOGY INTERNATIONAL
- Molecular networks in melanoma invasion and metastasis
- (2013) Ewa Aladowicz et al. Future Oncology
- Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma
- (2013) Paolo A. Ascierto et al. JOURNAL OF CLINICAL ONCOLOGY
- Extracellular Matrix Degradation and Remodeling in Development and Disease
- (2011) P. Lu et al. Cold Spring Harbor Perspectives in Biology
- Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness
- (2010) Srinivas Saladi et al. Molecular Cancer
- Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells
- (2009) Gabriel M. Gordon et al. JOURNAL OF CELLULAR PHYSIOLOGY
- BRAF(V600E) mutation and the biology of papillary thyroid cancer
- (2008) F Frasca et al. ENDOCRINE-RELATED CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started